What is Apprentice?
Headquartered in Jersey City, New Jersey, Apprentice provides a comprehensive platform designed to modernize the pharmaceutical manufacturing lifecycle. By integrating batch management, dynamic workflows, and global collaboration tools, the company enables life science organizations to accelerate the delivery of lifesaving medications. Apprentice serves as a digital backbone for teams responsible for executing safe and reliable production, effectively bridging the gap between complex laboratory research and large-scale commercial manufacturing through deep data insights and smart factory capabilities.
How much funding has Apprentice raised?
Apprentice has raised a total of $207M across 6 funding rounds:
Other Financing Round
$2.5M
Series A
$8M
Other Financing Round
$7.5M
Series B
$24M
Series C
$100M
Other Financing Round
$65M
Other Financing Round (2017): $2.5M with participation from Hemi Ventures and Silverton Partners
Series A (2018): $8M led by Hemi Ventures, Silverton Partners, GFR Fund, Pritzker Group, and The Venture Reality Fund
Other Financing Round (2020): $7.5M supported by Insight Partners
Series B (2020): $24M featuring Pritzker Group Venture Capital, GFR Fund, Insight Partners, Pacific Western Bank, and The Venture Reality Fund
Series C (2022): $100M backed by Silverton Partners, Insight Partners, Alkeon Capital Management, Colorcon Ventures, and Pacific Western Bank
Other Financing Round (2023): $65M with participation from ICONIQ Growth, Insight Partners, and Alkeon Capital Management
Key Investors in Apprentice
Insight Partners
A global venture capital and private equity firm that invests in high-growth technology and software companies, providing extensive operational support through their dedicated portfolio platform.
ICONIQ Growth
A growth-stage investment firm that partners with visionary entrepreneurs to build enduring companies, leveraging a unique ecosystem of founders and business leaders.
Silverton Partners
A prominent early-stage venture capital firm based in Austin, Texas, known for its active support of technology-driven companies and long-term partnership approach.
What's next for Apprentice?
With the recent infusion of capital, Apprentice is well-positioned to scale its operations and expand its footprint within the global pharmaceutical supply chain. The company is expected to prioritize the enhancement of its AI-driven analytics and spatial computing features, which are essential for maintaining compliance and operational efficiency in highly regulated environments. As the industry shifts toward more agile, decentralized manufacturing models, Apprentice's strategic focus will likely center on deepening its integration with existing enterprise systems and fostering broader adoption of its collaborative manufacturing platform among top-tier biopharmaceutical firms.
See full Apprentice company page
